首页> 外文OA文献 >Once daily long-acting beta2-agonists and long-acting muscarinic antagonists in a combined inhaler versus placebo for chronic obstructive pulmonary disease

【2h】

Once daily long-acting beta2-agonists and long-acting muscarinic antagonists in a combined inhaler versus placebo for chronic obstructive pulmonary disease

机译：曾经每天长效的β2-激动剂和长效的毒蕈碱拮抗剂，在慢性阻塞性肺病的组合吸入者与安慰剂中

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Usman Maqsood; Terence N Ho; Karen Palmer; Fiona JR Eccles; Mohammed Munavvar; Ran Wang; Iain Crossingham; David JW Evans;
展开▼
作者单位

展开▼
年度 2019
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Healthcare Resource Utilization, Exacerbations, and Readmissions Among Medicare Patients with Chronic Obstructive Pulmonary Disease After Long-Acting Muscarinic Antagonist Therapy Initiation with Soft Mist versus Dry Powder Inhalers [J] . David Singer, Lindsay GS Bengtson, Caitlin Elliott, International Journal of Chronic Obstructive Pulmonary Disease . 2020,第1期

机译：医疗保健资源利用率，慢性阻塞性肺病患者的慢性阻塞性肺病患者中的再服用，用软雾与干粉吸入器
2. Single inhaler extrafine triple therapy versus long-acting muscarinic antagonist therapy for chronic obstructive pulmonary disease (TRINITY): a double-blind, parallel group, randomised controlled trial [J] . Vestbo Jorgen, Papi Alberto, Corradi Massimo, The Lancet . 2017,第10082期

机译：单一吸入器外列三倍治疗与长效毒蕈碱拮抗剂治疗慢性阻塞性肺病（三位一体）：双盲，平行组，随机对照试验
3. Comparative Causal Analysis of the Effects of Long-Acting Muscarinic Antagonist Versus No Long-Acting Bronchodilator Use on Readmission or Mortality After Hospitalization for Chronic Obstructive Pulmonary Disease [J] . Melissa H. Roberts, Douglas W. Mapel, Hans Petersen Drugs - Real World Outcomes . 2020,第1期

机译：慢性阻塞性肺病住院后长效毒蕈碱拮抗剂对慢性阻塞性肺病后入院或死亡率影响的对比因果分析
4. CHRONIOUS: An open, ubiquitous and adaptive chronic disease management platform for Chronic Obstructive Pulmonary Disease (COPD), Chronic Kidney Disease (CKD) and renal insufficiency [C] . Rosso R., Munaro G., Salvetti O., 32nd Annual International Conference of the IEEE Engineering in Medicine and Biology Society . 2010

机译：慢性病：针对慢性阻塞性肺疾病（COPD），慢性肾脏病（CKD）和肾功能不全的开放，无处不在的适应性慢性疾病管理平台
5. Providing ethical care: Cardiopulmonary Resuscitation (CPR) for Chronic Obstructive Pulmonary Disease (COPD) Exacerbations in Patients with End Stage Lung Disease (ESLD). [D] . Young, Jeanne. 2010

机译：提供伦理护理：心肺复苏术（CPR）用于终末期肺病（ESLD）患者的慢性阻塞性肺疾病（COPD）加重。
6. Once daily long‐acting beta2‐agonists and long‐acting muscarinic antagonists in a combined inhaler versus placebo for chronic obstructive pulmonary disease [O] . Usman Maqsood, David JW Evans, Terence N Ho, -1

机译：每日一次长效β2受体激动剂和长效毒蕈碱拮抗剂在吸入器与安慰剂的组合中治疗慢性阻塞性肺疾病
7. Once-daily long-acting beta₂-agonists/inhaled corticosteroids combined inhalers versus inhaled long-acting muscarinic antagonists for people with chronic obstructive pulmonary disease [O] . Agnieszka Sliwka, Milosz Jankowski, Iwona Gross-Sondej, 2018

机译：曾经每日长效的β-β-激动剂/吸入皮质类固醇组合吸入器与慢性阻塞性肺病的人类吸入的长效肌肉蛋白拮抗剂

Once daily long-acting beta2-agonists and long-acting muscarinic antagonists in a combined inhaler versus placebo for chronic obstructive pulmonary disease

著录项

引文网络

相似文献

相关主题

期刊订阅